Back to Search
MICHAEL MICHAELSON, M.D.
M.D.
Internal Medicine Physician
NPI: 1669815734Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD15031(DC)
Research & Publications (20)
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PMID 19487381·J Clin Oncol·2009
3-trial
New treatments for renal cell carcinoma: targeted therapies.
PMID 19555586·J Natl Compr Canc Netw·2009
6-review
NCCN clinical practice guidelines in oncology: kidney cancer.
PMID 19555584·J Natl Compr Canc Netw·2009
6-review
A comparison of two mechanisms of severe paediatric injury in northern Israel.
PMID 19328486·Injury·2009
4-observational
NCCN clinical practice guidelines in oncology: testicular cancer.
PMID 19555582·J Natl Compr Canc Netw·2009
6-review
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.
PMID 18720362·Cancer·2008
8-other
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
PMID 18669461·J Clin Oncol·2008
3-trial
Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
PMID 18509125·N Engl J Med·2008
5-case
Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.
PMID 18765547·Clin Cancer Res·2008
3-trial
Transfusion medicine during the summer of 2006: lessons learned in northern Israel.
PMID 18063193·Transfus Med Rev·2008
8-other
[A seminar on the treatment of casualties of the Lebanon war 2006 at the Rambam Medical Center].
PMID 17674543·Harefuah·2007
8-other
The utility of focused assessment with sonography for trauma as a triage tool in multiple-casualty incidents during the second Lebanon war.
PMID 17715308·J Ultrasound Med·2007
8-other
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins.
PMID 17605814·J Transl Med·2007
3-trial
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.
PMID 17959415·Lancet Oncol·2007
3-trial
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
PMID 17215529·N Engl J Med·2007
3-trial
ASCO 2006 highlights: targeted therapy for renal cell carcinoma.
PMID 17367939·Cancer Treat Rev·2007
8-other
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.
PMID 17369566·J Clin Oncol·2007
4-observational
Case records of the Massachusetts General Hospital. Case 28-2006. A 59-year-old man with masses in both kidneys.
PMID 16971723·N Engl J Med·2006
5-case
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.
PMID 16804927·Cancer·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2939 VAN NESS ST NW, SUITE 618
WASHINGTON, DC 20008 - Phone
- (202) 362-2699
Quick Facts
- NPI
- 1669815734
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile